Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-02-16 4:07 pm Purchase | 2020-12-31 | 13G | Celldex Therapeutics, Inc. CLDX | Redmile Group, LLC | 2,711,616 6.900% | 2,711,616 (New Position) | Filing History |
| 2021-02-16 4:07 pm Purchase | 2020-12-31 | 13G | Cabaletta Bio, Inc. CABA | Redmile Group, LLC | 1,378,319 5.700% | 1,378,319 (New Position) | Filing History |
| 2021-02-16 4:06 pm Purchase | 2020-12-31 | 13G | Beam Therapeutics Inc. BEAM | Redmile Group, LLC | 3,778,262 6.500% | 3,778,262 (New Position) | Filing History |
| 2021-02-16 4:06 pm Purchase | 2020-12-31 | 13G | Ayala Pharmaceuticals, Inc. AYLA | Redmile Group, LLC | 667,816 5.200% | 667,816 (New Position) | Filing History |
| 2021-02-16 4:06 pm Purchase | 2020-12-31 | 13G | AVITA Medical, Inc. RCEL | Redmile Group, LLC | 1,707,386 7.900% | 1,707,386 (New Position) | Filing History |
| 2021-02-16 4:06 pm Purchase | 2020-12-31 | 13G | Atreca, Inc. BCEL | Redmile Group, LLC | 2,476,068 8.260% | 1,339,262 (+117.81%) | Filing History |
| 2021-02-16 4:06 pm Sale | 2020-12-31 | 13G | Aprea Therapeutics, Inc. APRE | Redmile Group, LLC | 63,436 5.990% | -50,000 (-44.08%) | Filing History |
| 2021-02-16 4:06 pm Purchase | 2020-12-31 | 13G | Annexon, Inc. ANNX | Redmile Group, LLC | 3,448,030 9.040% | 3,448,030 (New Position) | Filing History |
| 2021-02-16 4:06 pm Sale | 2020-12-31 | 13G | Amicus Therapeutics, Inc. FOLD | Redmile Group, LLC | 22,125,489 8.500% | -3,357,280 (-13.17%) | Filing History |
| 2021-02-16 4:06 pm Sale | 2020-12-31 | 13G | Allakos Inc. ALLK | Redmile Group, LLC | 2,667,451 5.080% | -366,075 (-12.07%) | Filing History |
| 2021-02-16 4:05 pm Purchase | 2020-12-31 | 13G | Akero Therapeutics, Inc. AKRO | Redmile Group, LLC | 2,322,557 6.690% | 2,322,557 (New Position) | Filing History |
| 2021-02-16 4:05 pm Purchase | 2020-12-31 | 13G | ADC Therapeutics S.A. ADCT | Redmile Group, LLC | 6,758,794 8.810% | 6,758,794 (New Position) | Filing History |
| 2021-01-12 4:18 pm Purchase | 2021-01-08 | 13D | Fate Therapeutics, Inc. FATE | Redmile Group, LLC | 12,993,888 14.100% | 332,152 (+2.62%) | Filing History |
| 2020-12-15 4:14 pm Purchase | 2020-12-11 | 13D | IGM Biosciences, Inc. IGMS | Redmile Group, LLC | 3,438,032 13.500% | 8,216 (+0.24%) | Filing History |